Only a small number of patients with pediatric cancer have germline or genetic mutations, mainly in APC or β-catenin, respectively [27,28,29], suggesting that mutation-independent mechanisms are involved in the development of HBL, HCN-NOS and perhaps pediatric HCC as well. Here, APC is linked to hepatoblastoma.